Effect of recombinant human erythropoietin on postoperative anemia in children and adolescents undergoing osteosarcoma and potential influencing factors: a single-center retrospective study
BackgroundRecombinant human erythropoietin (rhEPO) is an active glycoprotein secreted by the kidneys that improves anemia. The therapeutic role of rhEPO in anemia induced by surgical treatment after neoadjuvant chemotherapy in children and adolescents with osteosarcoma remains unclear. Additionally,...
I tiakina i:
| Ngā kaituhi matua: | , , , , , , |
|---|---|
| Hōputu: | Artigo |
| Reo: | Inglês |
| I whakaputaina: |
Frontiers Media S.A.
2025-11-01
|
| Rangatū: | Frontiers in Pharmacology |
| Ngā marau: | |
| Urunga tuihono: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1637441/full |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|